Copyright Reports & Markets. All rights reserved.

Global and Japan T-Cell Immunotherapy Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global T-Cell Immunotherapy Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 CAR-T
    • 1.2.3 TCR
    • 1.2.4 TIL Therapies
  • 1.3 Market by Application
    • 1.3.1 Global T-Cell Immunotherapy Market Share by Application: 2020 VS 2026
    • 1.3.2 Stomach Cancer
    • 1.3.3 Lung Cancer
    • 1.3.4 Colorectal Cancer
    • 1.3.5 Esophagus Cancer
    • 1.3.6 Pancreatic Cancer
    • 1.3.7 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global T-Cell Immunotherapy Market Perspective (2015-2026)
  • 2.2 Global T-Cell Immunotherapy Growth Trends by Regions
    • 2.2.1 T-Cell Immunotherapy Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 T-Cell Immunotherapy Historic Market Share by Regions (2015-2020)
    • 2.2.3 T-Cell Immunotherapy Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top T-Cell Immunotherapy Players by Market Size
    • 3.1.1 Global Top T-Cell Immunotherapy Players by Revenue (2015-2020)
    • 3.1.2 Global T-Cell Immunotherapy Revenue Market Share by Players (2015-2020)
  • 3.2 Global T-Cell Immunotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by T-Cell Immunotherapy Revenue
  • 3.4 Global T-Cell Immunotherapy Market Concentration Ratio
    • 3.4.1 Global T-Cell Immunotherapy Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by T-Cell Immunotherapy Revenue in 2019
  • 3.5 Key Players T-Cell Immunotherapy Area Served
  • 3.6 Key Players T-Cell Immunotherapy Product Solution and Service
  • 3.7 Date of Enter into T-Cell Immunotherapy Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 T-Cell Immunotherapy Breakdown Data by Type (2015-2026)

  • 4.1 Global T-Cell Immunotherapy Historic Market Size by Type (2015-2020)
  • 4.2 Global T-Cell Immunotherapy Forecasted Market Size by Type (2021-2026)

5 T-Cell Immunotherapy Breakdown Data by Application (2015-2026)

  • 5.1 Global T-Cell Immunotherapy Historic Market Size by Application (2015-2020)
  • 5.2 Global T-Cell Immunotherapy Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America T-Cell Immunotherapy Market Size (2015-2026)
  • 6.2 North America T-Cell Immunotherapy Market Size by Type (2015-2020)
  • 6.3 North America T-Cell Immunotherapy Market Size by Application (2015-2020)
  • 6.4 North America T-Cell Immunotherapy Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe T-Cell Immunotherapy Market Size (2015-2026)
  • 7.2 Europe T-Cell Immunotherapy Market Size by Type (2015-2020)
  • 7.3 Europe T-Cell Immunotherapy Market Size by Application (2015-2020)
  • 7.4 Europe T-Cell Immunotherapy Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China T-Cell Immunotherapy Market Size (2015-2026)
  • 8.2 China T-Cell Immunotherapy Market Size by Type (2015-2020)
  • 8.3 China T-Cell Immunotherapy Market Size by Application (2015-2020)
  • 8.4 China T-Cell Immunotherapy Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan T-Cell Immunotherapy Market Size (2015-2026)
  • 9.2 Japan T-Cell Immunotherapy Market Size by Type (2015-2020)
  • 9.3 Japan T-Cell Immunotherapy Market Size by Application (2015-2020)
  • 9.4 Japan T-Cell Immunotherapy Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia T-Cell Immunotherapy Market Size (2015-2026)
  • 10.2 Southeast Asia T-Cell Immunotherapy Market Size by Type (2015-2020)
  • 10.3 Southeast Asia T-Cell Immunotherapy Market Size by Application (2015-2020)
  • 10.4 Southeast Asia T-Cell Immunotherapy Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

  • 11.1 Adaptimmune
    • 11.1.1 Adaptimmune Company Details
    • 11.1.2 Adaptimmune Business Overview
    • 11.1.3 Adaptimmune T-Cell Immunotherapy Introduction
    • 11.1.4 Adaptimmune Revenue in T-Cell Immunotherapy Business (2015-2020))
    • 11.1.5 Adaptimmune Recent Development
  • 11.2 Altor Bioscience Corporation
    • 11.2.1 Altor Bioscience Corporation Company Details
    • 11.2.2 Altor Bioscience Corporation Business Overview
    • 11.2.3 Altor Bioscience Corporation T-Cell Immunotherapy Introduction
    • 11.2.4 Altor Bioscience Corporation Revenue in T-Cell Immunotherapy Business (2015-2020)
    • 11.2.5 Altor Bioscience Corporation Recent Development
  • 11.3 Cellectis
    • 11.3.1 Cellectis Company Details
    • 11.3.2 Cellectis Business Overview
    • 11.3.3 Cellectis T-Cell Immunotherapy Introduction
    • 11.3.4 Cellectis Revenue in T-Cell Immunotherapy Business (2015-2020)
    • 11.3.5 Cellectis Recent Development
  • 11.4 Juno Therapeutics
    • 11.4.1 Juno Therapeutics Company Details
    • 11.4.2 Juno Therapeutics Business Overview
    • 11.4.3 Juno Therapeutics T-Cell Immunotherapy Introduction
    • 11.4.4 Juno Therapeutics Revenue in T-Cell Immunotherapy Business (2015-2020)
    • 11.4.5 Juno Therapeutics Recent Development
  • 11.5 Kite Pharma
    • 11.5.1 Kite Pharma Company Details
    • 11.5.2 Kite Pharma Business Overview
    • 11.5.3 Kite Pharma T-Cell Immunotherapy Introduction
    • 11.5.4 Kite Pharma Revenue in T-Cell Immunotherapy Business (2015-2020)
    • 11.5.5 Kite Pharma Recent Development
  • 11.6 Novartis
    • 11.6.1 Novartis Company Details
    • 11.6.2 Novartis Business Overview
    • 11.6.3 Novartis T-Cell Immunotherapy Introduction
    • 11.6.4 Novartis Revenue in T-Cell Immunotherapy Business (2015-2020)
    • 11.6.5 Novartis Recent Development
  • 11.7 Takara Bio
    • 11.7.1 Takara Bio Company Details
    • 11.7.2 Takara Bio Business Overview
    • 11.7.3 Takara Bio T-Cell Immunotherapy Introduction
    • 11.7.4 Takara Bio Revenue in T-Cell Immunotherapy Business (2015-2020)
    • 11.7.5 Takara Bio Recent Development
  • 11.8 Unum Therapeutics
    • 11.8.1 Unum Therapeutics Company Details
    • 11.8.2 Unum Therapeutics Business Overview
    • 11.8.3 Unum Therapeutics T-Cell Immunotherapy Introduction
    • 11.8.4 Unum Therapeutics Revenue in T-Cell Immunotherapy Business (2015-2020)
    • 11.8.5 Unum Therapeutics Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global T-Cell Immunotherapy Scope and Market Size
    T-Cell Immunotherapy market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global T-Cell Immunotherapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    CAR-T
    TCR
    TIL Therapies

    Market segment by Application, split into
    Stomach Cancer
    Lung Cancer
    Colorectal Cancer
    Esophagus Cancer
    Pancreatic Cancer
    Others

    Based on regional and country-level analysis, the T-Cell Immunotherapy market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa

    In the competitive analysis section of the report, leading as well as prominent players of the global T-Cell Immunotherapy market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    Adaptimmune
    Altor Bioscience Corporation
    Cellectis
    Juno Therapeutics
    Kite Pharma
    Novartis
    Takara Bio
    Unum Therapeutics

    Buy now